Outlook Therapeutics OTLK Q1 2026 Earnings Miss by Significant Key Takeaways LiveWire Group LVWR Q1 2026 In Line Whats Next for Investors TherapeuticsMD TXMD Climbs 196 Resistance at 218 in Focus 20260520 Casella CWST Jumps 077 on Strong Momentum 20260520 BYD Eyes European Expansion Talks to Acquire Idle Plants from Stellantis Including Potential Maserati Link Western WRN Up 266 Is There More Room to Run 20260520